Dr Sandar Tin Tin
Contact information
Research groups
Sandar Tin Tin
MBBS, MPH, PhD
Girdlers’ New Zealand HRC Fellow
Sandar joined the Cancer Epidemiology Unit (CEU) as a Girdlers’ New Zealand HRC (Health Research Council) Fellow in August 2019.
Her current research is based on the UK Biobank and examines physical activity, biomarkers and breast cancer risk.
Sandar has a broad interest in the theoretical, methodological and applied aspects of epidemiological research, and has undertaken a number of research projects related to cancer, active travel, injury and child and youth health.
She was trained as a medical doctor in Myanmar and holds a Master of Public Health and a PhD from the University of Auckland, New Zealand.
Recent publications
-
Beta blocker use and breast cancer survival by subtypes: A population-based cohort study.
Scott OW. et al, (2025), Breast, 81
-
Reproductive Factors, Sex Hormone Levels, and Differentiated Thyroid Cancer Risk: A Mendelian Randomization Study.
Park SH. et al, (2025), Thyroid
-
Treatment Outcomes From Erlotinib and Gefitinib in Advanced Epidermal Growth Factor Receptor-Mutated Nonsquamous Non-Small Cell Lung Cancer in Aotearoa New Zealand From 2010 to 2020: Nationwide Whole-of-Patient-Population Retrospective Cohort Study.
Aye PS. et al, (2025), JMIR Cancer, 11
-
Incidence trends of ductal carcinoma in situ in New Zealand women between 1999 and 2022.
Chen Q. et al, (2025), Breast Cancer Res Treat
-
Outcomes from low-risk ductal carcinoma in situ: a systematic review and meta-analysis.
Chen Q. et al, (2024), Breast Cancer Res Treat